mechlorethamine has been researched along with Malignant Melanoma in 55 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous NMR studies demonstrated that lonidamine (LND) selectively diminishes the intracellular pH (pHi) of DB-1 melanoma and mouse xenografts of a variety of other prevalent human cancers while decreasing their bioenergetic status (tumor βNTP/Pi ratio) and enhancing the activities of melphalan and doxorubicin in these cancer models." | 7.83 | Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice. ( Garman, B; Glickson, JD; Leeper, DB; Nath, K; Nathanson, KL; Nelson, DS; Putt, ME, 2016) |
| "In the human melanoma cell line MM127 , the melphalan survival curve was linear and exhibited reciprocity with respect to concentration and treatment time." | 7.67 | Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines. ( Parsons, PG, 1984) |
| "The formation and removal of nitrogen mustard (HN2)- and melphalan-induced DNA cross-links (DNA interstrand and DNA-protein cross-links) in a human melanoma cell line (RPMI 8322), as determined by alkaline elution of DNA, was compared and related to the cytotoxic effect of each drug." | 7.67 | Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. ( Hansson, J; Lewensohn, R; Nilsson, B; Ringborg, U, 1987) |
| "Forty-two patients with intransit metastases of melanoma in a limb were treated by isolated regional perfusion chemotherapy using mechlorethamine (nitrogen mustard)." | 7.67 | Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). ( Fortner, JG; Gould-Rossbach, P; Guerra, J; Horowitz, G; Knapper, WH; Ray, C; Schnog, J; Shiu, MH; Yeh, S, 1986) |
| " The additional use of mechlorethamine or oral psoralen plus UV-A, but not radiation, was significantly associated with the development of basal cell carcinoma and squamous cell carcinoma, but not malignant melanoma." | 4.79 | Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. ( Braverman, IM; Feldman, AM; Kacinski, BM; Licata, AG; Wilson, LD, 1995) |
| "Previous NMR studies demonstrated that lonidamine (LND) selectively diminishes the intracellular pH (pHi) of DB-1 melanoma and mouse xenografts of a variety of other prevalent human cancers while decreasing their bioenergetic status (tumor βNTP/Pi ratio) and enhancing the activities of melphalan and doxorubicin in these cancer models." | 3.83 | Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice. ( Garman, B; Glickson, JD; Leeper, DB; Nath, K; Nathanson, KL; Nelson, DS; Putt, ME, 2016) |
| "The cytotoxic effects of the bifunctional DNA-reactive drugs cisplatin, mustine and melphalan were studied in two human melanoma cell lines, RPMI 8322 and A 375." | 3.68 | Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin. ( Edgren, M; Fichtinger-Schepman, AM; Hansson, J; Ringborg, U, 1991) |
| "In the human melanoma cell line MM127 , the melphalan survival curve was linear and exhibited reciprocity with respect to concentration and treatment time." | 3.67 | Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines. ( Parsons, PG, 1984) |
| "The formation and removal of nitrogen mustard (HN2)- and melphalan-induced DNA cross-links (DNA interstrand and DNA-protein cross-links) in a human melanoma cell line (RPMI 8322), as determined by alkaline elution of DNA, was compared and related to the cytotoxic effect of each drug." | 3.67 | Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. ( Hansson, J; Lewensohn, R; Nilsson, B; Ringborg, U, 1987) |
| "Forty-two patients with intransit metastases of melanoma in a limb were treated by isolated regional perfusion chemotherapy using mechlorethamine (nitrogen mustard)." | 3.67 | Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). ( Fortner, JG; Gould-Rossbach, P; Guerra, J; Horowitz, G; Knapper, WH; Ray, C; Schnog, J; Shiu, MH; Yeh, S, 1986) |
| "Thirteen patients with advanced (Stage III) malignant melanoma have been treated with high-dose chemotherapy (nitrogen mustard or a combination of BCNU and melphalan) combined with autologous, nonfrozen, bone marrow transplantation." | 3.66 | Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study. ( Dantas, ME; Glode, LM; Koeppler, H; Morton, N; Robinson, WA; Sutherland, J; Thomas, MR, 1982) |
| " It is the authors' conclusion that the portable isolated limb perfusion system achieved all of the required parameters to provide safe and effective treatment for this type of melanoma." | 1.29 | Safe, compact and portable system for regional chemotherapeutic hyperthermic perfusion procedures. ( Faddis, D; Fried, SJ; Miller, R; Weaver, FA, 1993) |
| " Cytostatics are dosed per liter of perfused extremity." | 1.27 | [Technic of isolated perfusion of the extremities. Experience with 171 cases]. ( Aigner, K; Schwemmle, K, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (83.64) | 18.7374 |
| 1990's | 7 (12.73) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (3.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyons, AB | 1 |
| Mitchell, DA | 1 |
| Moy, RL | 2 |
| Nath, K | 1 |
| Nelson, DS | 1 |
| Putt, ME | 1 |
| Leeper, DB | 1 |
| Garman, B | 1 |
| Nathanson, KL | 1 |
| Glickson, JD | 1 |
| LUCK, JM | 1 |
| CREECH, O | 4 |
| RYAN, RF | 4 |
| KREMENTZ, ET | 5 |
| HOLLAND, JF | 1 |
| REGELSON, W | 2 |
| WESTBURY, G | 1 |
| HUMBLE, JG | 1 |
| NEWTON, KA | 1 |
| SKINNER, ME | 1 |
| PEGG, DE | 1 |
| IRVINE, WT | 1 |
| NOON, CF | 1 |
| MANIZADE, D | 1 |
| SALEPCIOGLU, A | 1 |
| AKTAN, K | 1 |
| ARIEL, IM | 1 |
| PACK, GT | 1 |
| KENNEDY, BJ | 1 |
| ZELICKSON, AS | 1 |
| CALCUTT, G | 1 |
| CONNORS, TA | 1 |
| BRINDLEY, CO | 1 |
| SALVIN, LG | 1 |
| POTEE, KG | 1 |
| LIPOWSKA, B | 1 |
| SHNIDER, BI | 1 |
| COLSKY, J | 1 |
| BOGUSZ, J | 1 |
| BUTELSKI, W | 1 |
| SYCH, M | 1 |
| THIELE, EH | 1 |
| ARISON, RN | 1 |
| BOXER, GE | 1 |
| MAUER, AM | 1 |
| KRILL, CE | 1 |
| VIGI, F | 1 |
| SHINGLETON, WW | 1 |
| PARKER, RT | 1 |
| DOWD, JE | 1 |
| DIPAOLO, JA | 1 |
| WATNE, AL | 1 |
| FRIEDMAN, BI | 1 |
| SAENGER, EL | 1 |
| KREINDLER, MS | 1 |
| DECOSSE, JJ | 1 |
| ROGERS, LS | 1 |
| LAWRENCE, W | 1 |
| TAYAO, MS | 1 |
| MAHAJAN, RD | 1 |
| PAGE, R | 1 |
| MILLER, DG | 1 |
| CLAPP, P | 1 |
| KONDO, T | 1 |
| ICHIHASHI, H | 1 |
| BIRINGER, A | 1 |
| HOLAN, J | 1 |
| MEDLA, F | 1 |
| JONES, KO | 1 |
| REEVE, TS | 1 |
| PIPER, DW | 1 |
| CUMBERLAND, VH | 1 |
| Markman, M | 1 |
| Aigner, K | 2 |
| Schwemmle, K | 1 |
| Cosnes, A | 1 |
| Revuz, J | 1 |
| Wechsler, J | 1 |
| Touraine, R | 1 |
| Parsons, PG | 1 |
| Thomas, MR | 1 |
| Robinson, WA | 2 |
| Glode, LM | 2 |
| Dantas, ME | 1 |
| Koeppler, H | 1 |
| Morton, N | 1 |
| Sutherland, J | 1 |
| Hofer, D | 2 |
| Dubitsky, AM | 1 |
| Reïlly, P | 2 |
| Santoro, MG | 3 |
| Jaffe, BM | 3 |
| Dubitsky, A | 1 |
| Marti, J | 1 |
| Hild, P | 1 |
| Hundeiker, M | 1 |
| Hartmann, DW | 1 |
| Morton, NJ | 1 |
| Mangalik, A | 1 |
| Leport, P | 1 |
| Favalli, C | 1 |
| Rinaldi, C | 1 |
| Licata, AG | 1 |
| Wilson, LD | 1 |
| Braverman, IM | 1 |
| Feldman, AM | 1 |
| Kacinski, BM | 1 |
| Quinn, TD | 1 |
| Polk, HC | 1 |
| Edwards, MJ | 1 |
| Carter, RD | 1 |
| Sutherland, CM | 1 |
| Muchmore, JH | 1 |
| Lamb, PM | 1 |
| Menaker, GM | 1 |
| Amichai, B | 1 |
| Grunwald, MH | 1 |
| Goldstein, J | 1 |
| Finkelstein, E | 1 |
| Halevy, S | 1 |
| Fried, SJ | 1 |
| Miller, R | 1 |
| Weaver, FA | 1 |
| Faddis, D | 1 |
| Klein, E | 1 |
| Rosner, D | 1 |
| Holtermann, OA | 1 |
| Stoll, HL | 1 |
| Song, SY | 1 |
| Hansson, J | 2 |
| Fichtinger-Schepman, AM | 1 |
| Edgren, M | 1 |
| Ringborg, U | 2 |
| Lewensohn, R | 1 |
| Nilsson, B | 1 |
| Shiu, MH | 1 |
| Knapper, WH | 1 |
| Fortner, JG | 1 |
| Yeh, S | 1 |
| Horowitz, G | 1 |
| Schnog, J | 1 |
| Guerra, J | 1 |
| Gould-Rossbach, P | 1 |
| Ray, C | 1 |
| Helman, P | 1 |
| Sealy, R | 1 |
| Malherbe, E | 1 |
| Anderson, J | 1 |
| Anderson, CB | 1 |
| Philpott, GW | 1 |
| Ferguson, TB | 1 |
| Hill, GJ | 1 |
| Larsen, RR | 1 |
| Hersh, EM | 1 |
| McBride, CM | 2 |
| Gschwind, C | 1 |
| Mahaley, MS | 1 |
| Woodhall, B | 1 |
| Jelicić, I | 1 |
| Pasini, M | 1 |
| Prpić, I | 1 |
| Relja-Vladović, T | 1 |
| Hancević, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Melphalan Intra-arterial Chemotherapy for Choroidal Melanoma Chemoreduction - a Phase I Clinical Trial[NCT05893654] | Phase 1/Phase 2 | 10 participants (Anticipated) | Interventional | 2021-05-01 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mechlorethamine and Malignant Melanoma
| Article | Year |
|---|---|
Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Electrons; Female; Humans; Lymphoma, T | 1995 |
1 trial available for mechlorethamine and Malignant Melanoma
| Article | Year |
|---|---|
Newer techniques in cancer chemotherapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bleomycin; Bone Marrow Transplantation; Carcinoma; Ce | 1984 |
53 other studies available for mechlorethamine and Malignant Melanoma
| Article | Year |
|---|---|
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2019 |
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell S | 2016 |
The action of the phenylalanine mustards and of several homologs on mouse melanoma.
Topics: Animals; Mechlorethamine; Melanoma; Melphalan; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1957 |
Treatment of melanoma by isolation-perfusion technique.
Topics: Humans; Leg; Mechlorethamine; Melanoma; Neoplasms; Nitrogen Mustard Compounds; Perfusion; Phenylalan | 1959 |
Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.
Topics: Humans; Mechlorethamine; Melanoma; Nitrogen Mustard Compounds; Phenylalanine | 1958 |
A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin's disease, lymphosarcoma, and melanoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Hodgkin Disease; Humans; Leucine; Lymphoma; Lymphoma | 1959 |
Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.
Topics: Antineoplastic Agents; Bone Marrow; Cytotoxins; Mannitol; Mechlorethamine; Melanoma; Nitrogen Mustar | 1959 |
The treatment of malignant melanoma by perfusion techniques.
Topics: Humans; Mechlorethamine; Melanoma; Nitrogen Mustard Compounds; Perfusion | 1961 |
[A case of malignant melanoma of the leg treated by isolated perfusion of nitrogen mustard].
Topics: Extracorporeal Circulation; Humans; Leg; Mechlorethamine; Melanoma; Nitrogen Mustard Compounds; Perf | 1960 |
Treatment of disseminated melanoma with phenylalanine mustard (melphelan) and autogenous bone marrow transplants.
Topics: Bone Marrow; Bone Marrow Transplantation; Humans; Mechlorethamine; Melanoma; Melphalan; Nitrogen Mus | 1962 |
Chemotherapy of melanoma of the extremities by isolated perfusion.
Topics: Antineoplastic Agents; Extremities; Mechlorethamine; Melanoma; Neoplasms; Nitrogen Mustard Compounds | 1962 |
MELANOMA IN AN ALBINO.
Topics: Albinism; Electrons; Mechlorethamine; Melanins; Melanoma; Microscopy; Microscopy, Electron; Neoplasm | 1963 |
TUMOUR SULPHYDRYL LEVELS AND SENSITIVITY TO THE NITROGEN MUSTARD MEROPHAN.
Topics: Animals; Lymphoma; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mechlorethamine; Mela | 1963 |
FURTHER COMPARATIVE TRIAL OF TRIETHYLENE THIOPHOSPHORAMIDE AND MECHLORETHAMINE IN PATIENTS WITH MELANOMA AND HODGKIN'S DISEASE.
Topics: District of Columbia; Hodgkin Disease; Mechlorethamine; Melanoma; New York; Thiotepa; Toxicology | 1964 |
[RESULTS IN THE CHEMOTHERAPY OF MALIGNANT NEOPLASMS USING THE APPARATUS FOR EXTRACORPOREAL CIRCULATION].
Topics: Chemotherapy, Cancer, Regional Perfusion; Extracorporeal Circulation; Heart, Artificial; Humans; Leg | 1963 |
ONCOLYSIS BY CLOSTRIDIA. III. EFFECTS OF CLOSTRIDIA AND CHEMOTHERAPEUTIC AGENTS ON RODENT TUMORS.
Topics: Adenocarcinoma; Animals; Antimetabolites; Antineoplastic Agents; Aziridines; Bacteriological Techniq | 1964 |
A STUDY OF THE MECHANISMS OF GRANULOCYTOPENIA.
Topics: Agranulocytosis; Anemia; Anemia, Macrocytic; Carcinoma; Carcinoma, Bronchogenic; Child; Hodgkin Dise | 1964 |
[ANTINEOPLASTIC PREPARATIONS USED AS A MEANS OF PROTECTION AGAINST THE FREE ELEMENTS IN THE BLOOD AND CONTAMINATION BY NEOPLASTIC CELLS, IN OPERATIVE INTERVENTIONS].
Topics: Antineoplastic Agents; Carcinoma; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Melano | 1963 |
REGIONAL PERFUSION IN MELANOMA OF LIMBS.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Extremities; Humans; Mechlorethamin | 1964 |
ABDOMINAL PERFUSION FOR CANCER CHEMOTHERAPY USING HYPOTHERMIA AND HYPERTHERMIA.
Topics: Abdomen; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Cycloph | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
ENDOREDUPLICATION IN LEUCOCYTE CHROMOSOMES. PRELIMINARY REPORT OF ITS RELATION TO CANCER AND WHOLE-BODY IRRADIATION.
Topics: Breast Neoplasms; Chromosome Aberrations; Chromosome Disorders; Chromosomes; Cobalt Isotopes; Coloni | 1964 |
EFFECT OF HYPERBARIC OXYGEN AND CANCER CHEMOTHERAPY ON GROWTH OF ANIMAL TUMORS.
Topics: Animals; Cricetinae; Humans; Hyperbaric Oxygenation; Injections, Intraperitoneal; Lung Neoplasms; Me | 1964 |
SYSTEMIC THIOSULFATE PROTECTION DURING FRACTIONATED REGIONAL NITROGEN MUSTARD THERAPY.
Topics: Biomedical Research; Carcinoma; Carcinoma, Squamous Cell; Dogs; Geriatrics; Infusions, Parenteral; I | 1964 |
[INDUCTION OF METASTASES BY TREATMENT WITH CARCINOSTATIC AGENTS. II. DEPRESSION OF HOST RESISTANCE AND ANTIBODY PRODUCTION].
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Cattle; Chemotherapy, Cancer, Regional Perfusion | 1964 |
OUR EXPERIENCES WITH CYTOSTATIC PERFUSIONS OF THE EXTREMITIES IN THE TREATMENT OF MALIGNANT TUMORS.
Topics: Animals; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Dogs; Drug Ther | 1964 |
Disseminated abdominal melanoma treated by massive dosage of nitrogen mustard and autogenous bone-marrow replacement.
Topics: Bone Marrow; Bone Marrow Transplantation; Humans; Mechlorethamine; Medical Records; Melanoma; Nitrog | 1960 |
[Technic of isolated perfusion of the extremities. Experience with 171 cases].
Topics: Arm; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Drug Therapy, Combination; Ex | 1983 |
[Melanoma and dysplastic nevus after 8 years of topical Caryolysine].
Topics: Administration, Topical; Female; Humans; Mechlorethamine; Melanoma; Middle Aged; Nevus, Pigmented; P | 1984 |
Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
Topics: Caffeine; Cell Line; Cell Survival; Chlorambucil; DNA, Neoplasm; Drug Resistance; Drug Synergism; Ho | 1984 |
Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; | 1982 |
The interactions between indomethacin and cytotoxic drugs in mice bearing B-16 melanomas.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Cell Count; Cell Division; Doxorubicin; Female; Fluorouraci | 1980 |
Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo.
Topics: Animals; Antineoplastic Agents; Dopamine; Doxorubicin; Drug Therapy, Combination; Female; Fluorourac | 1982 |
[New modifications in isolated extremity perfusion ].
Topics: Antineoplastic Agents; Arm; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Dactin | 1982 |
High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trial.
Topics: Adolescent; Bone Marrow Transplantation; Drug Evaluation; Female; Humans; Hypocalcemia; Male; Mechlo | 1981 |
PGE restores the immune response in chemotherapy-treated, tumor-bearing mice.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Antibody Formation; Doxorubicin; Drug Therapy, Combination; | 1982 |
Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Combined M | 1995 |
Regional chemotherapy for melanoma. A 35-year experience.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Combined Modality T | 1994 |
Multiple basal cell carcinomas of the limb after adjuvant treatment of melanoma with isolated limb perfusion.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Chemotherapy, Canc | 1998 |
Small malignant melanoma in patients with mycosis fungoides.
Topics: Adult; Antineoplastic Agents, Alkylating; Humans; Male; Mechlorethamine; Melanoma; Middle Aged; Myco | 1998 |
Safe, compact and portable system for regional chemotherapeutic hyperthermic perfusion procedures.
Topics: Adult; Aged; Arm; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; | 1993 |
Nonspecific antigen reactions.
Topics: Administration, Topical; Antibody Formation; Antigens; Antineoplastic Agents; BCG Vaccine; Breast Ne | 1976 |
Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin.
Topics: Cell Line; Cell Survival; Cisplatin; DNA, Neoplasm; Glutathione; Humans; Mechlorethamine; Melanoma; | 1991 |
Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells.
Topics: Cell Line; Cell Survival; DNA; Humans; Mathematics; Mechlorethamine; Melanoma; Melphalan; Neoplastic | 1987 |
Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard).
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Extremities; Female; Humans; Hyperthermia, In | 1986 |
Intra-arterial cytotoxic therapy and x-ray therapy for cancer of the head and neck.
Topics: Adenoma, Pleomorphic; Carcinoma, Squamous Cell; Facial Neoplasms; Fibrosarcoma; Head; Head and Neck | 1965 |
The treatment of malignant pleural effusions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamou | 1974 |
Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
Topics: Adult; Aged; Arm; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Leg; Male; Mechlorethami | 1972 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; | 1972 |
Local and systemic immunologic effects of perfusion therapy for malignant melanoma.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; E | 1973 |
Regional chemotherapeutic perfusion and infusion of brain and face tumors.
Topics: Adenocarcinoma; Ameloblastoma; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carcinoma; Carci | 1967 |
[Regional perfusion with nitrogen mustard in the treatment of malignant tumors of the lower extremities].
Topics: Adolescent; Adult; Angiokeratoma; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion | 1969 |
Advanced melanoma of the extremities.
Topics: Adolescent; Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Child; Dactinomycin; Female; Huma | 1970 |